| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BOK |
BOK: Bcl-2-related ovarian killer protein |
2.622 |
Evidence |
|
| TRPV3 |
IPI00555580 |
RYR2 |
RYR2: Ryanodine receptor 2 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
2.622 |
Evidence |
|
| BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
2.622 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-67 alpha chain precursor |
2.622 |
Evidence |
|
| CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
2.622 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
NTRK3 |
IPI00289961 |
2.622 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
2.622 |
Evidence |
|
| KCNA5 |
KCNA5: Potassium voltage-gated channel subfamily A member 5 |
KCND3 |
KCND3: Potassium voltage-gated channel subfamily D member 3 |
2.622 |
Evidence |
|
| NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-38 alpha chain precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
2.622 |
Evidence |
|
| CACNA1G |
IPI00219398 |
TRPC1 |
TRPC1, TRP1: Short transient receptor potential channel 1 |
2.622 |
Evidence |
|
| IFI16 |
IFI16, IFNGIP1: Gamma-interferon-inducible protein Ifi-16 |
CARD15 |
NOD2, CARD15, IBD1: Nucleotide-binding oligomerization domain-containing protein |
2.622 |
Evidence |
|
| KCNE1 |
KCNE1: Potassium voltage-gated channel subfamily E member 1 |
KCNQ1 |
KCNQ1, KCNA8, KCNA9, KVLQT1: Potassium voltage-gated channel subfamily KQT membe |
2.622 |
Evidence |
|
| SIM1 |
SIM1: Single-minded homolog 1 |
MXD1 |
MXD1, MAD: MAD protein |
2.622 |
Evidence |
|
| SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
PKD2 |
IPI00718868 |
2.622 |
Evidence |
|
| FES |
FES, FPS: Proto-oncogene tyrosine-protein kinase Fes/Fps |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
2.622 |
Evidence |
|
| BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.622 |
Evidence |
|
| MPDZ |
MPDZ, MUPP1: Multiple PDZ domain protein |
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
2.622 |
Evidence |
|
| RAB36 |
RAB36: Ras-related protein Rab-36 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
2.622 |
Evidence |
|
| LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
CALR |
CALR, CRTC: Calreticulin precursor |
2.622 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
2.62 |
Evidence |
|
| CSH2 |
GH1: Somatotropin precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
2.62 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
2.62 |
Evidence |
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
RYR2 |
RYR2: Ryanodine receptor 2 |
2.62 |
Evidence |
|
| CD5 |
CD5, LEU1: T-cell surface glycoprotein CD5 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
2.62 |
Evidence |
|